Dolca Thomas

Dolca Thomas, MD, currently serves on the Board of Directors for UCB and Allakos Inc., along with being a member of the Scientific Advisory Board for AnaptysBio and a Venture Partner at Samsara BioCapital. Thomas has extensive experience in the biotechnology field, previously holding leadership roles such as Director on the Board at Chinook Therapeutics, Chief Medical Officer at Principia Biopharma, and Executive Vice President at Equillium, Inc. Notably, Thomas has contributed to impactful acquisitions, including the acquisition of Chinook by Novartis and Principia by Sanofi. Educational background includes degrees in Medicine and Nephrology from the Joan & Sanford I. Weill Medical College of Cornell University and an undergraduate degree from Cornell University.